These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 12470807)
41. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835 [TBL] [Abstract][Full Text] [Related]
42. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Mueller-Steiner S; Zhou Y; Arai H; Roberson ED; Sun B; Chen J; Wang X; Yu G; Esposito L; Mucke L; Gan L Neuron; 2006 Sep; 51(6):703-14. PubMed ID: 16982417 [TBL] [Abstract][Full Text] [Related]
43. Rapid cerebral amyloid binding by Aβ antibodies infused into β-amyloid precursor protein transgenic mice. Winkler DT; Abramowski D; Danner S; Zurini M; Paganetti P; Tolnay M; Staufenbiel M Biol Psychiatry; 2010 Nov; 68(10):971-4. PubMed ID: 20359696 [TBL] [Abstract][Full Text] [Related]
44. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease. Zhang Z; Song M; Liu X; Su Kang S; Duong DM; Seyfried NT; Cao X; Cheng L; Sun YE; Ping Yu S; Jia J; Levey AI; Ye K Nat Commun; 2015 Nov; 6():8762. PubMed ID: 26549211 [TBL] [Abstract][Full Text] [Related]
45. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions. van Groen T; Liu L; Ikonen S; Kadish I Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872 [TBL] [Abstract][Full Text] [Related]
46. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance. Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195 [TBL] [Abstract][Full Text] [Related]
48. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology. Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311 [TBL] [Abstract][Full Text] [Related]
49. Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels. Schäfer S; Pajonk FG; Multhaup G; Bayer TA J Mol Med (Berl); 2007 Apr; 85(4):405-13. PubMed ID: 17211610 [TBL] [Abstract][Full Text] [Related]
50. Metals and amyloid-beta in Alzheimer's disease. Maynard CJ; Bush AI; Masters CL; Cappai R; Li QX Int J Exp Pathol; 2005 Jun; 86(3):147-59. PubMed ID: 15910549 [TBL] [Abstract][Full Text] [Related]
51. Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice. Lillehaug S; Syverstad GH; Nilsson LN; Bjaalie JG; Leergaard TB; Torp R Neurobiol Aging; 2014 Mar; 35(3):556-64. PubMed ID: 24126157 [TBL] [Abstract][Full Text] [Related]
52. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease. Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574 [TBL] [Abstract][Full Text] [Related]
53. Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease. Egensperger R; Weggen S; Ida N; Multhaup G; Schnabel R; Beyreuther K; Bayer TA Acta Neuropathol; 1999 Feb; 97(2):113-8. PubMed ID: 9928821 [TBL] [Abstract][Full Text] [Related]
54. Transient appearance of amyloid precursor protein plaques in the brain of thymectomized rats after human leptomeningeal cell grafts. DeGiorgio LA; Manuelidis L; Bernstein JJ Neurosci Lett; 2002 Mar; 322(1):62-6. PubMed ID: 11958844 [TBL] [Abstract][Full Text] [Related]
55. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis. Castello MA; Soriano S Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390 [TBL] [Abstract][Full Text] [Related]
56. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. DeMattos RB; O'dell MA; Parsadanian M; Taylor JW; Harmony JA; Bales KR; Paul SM; Aronow BJ; Holtzman DM Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10843-8. PubMed ID: 12145324 [TBL] [Abstract][Full Text] [Related]
57. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model. Baik SH; Kang S; Son SM; Mook-Jung I Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617 [TBL] [Abstract][Full Text] [Related]
59. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease. Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705 [TBL] [Abstract][Full Text] [Related]
60. BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo. Lee EB; Zhang B; Liu K; Greenbaum EA; Doms RW; Trojanowski JQ; Lee VM J Cell Biol; 2005 Jan; 168(2):291-302. PubMed ID: 15642747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]